To the Editor: Loupy et al. (Sept. 26 issue) 1 present data showing that the C1q-binding assay is more sensitive than the standard complement-dependent microlymphocytotoxicity (CDL) assay for ...
Pembrolizumab in gastrointestinal (GI) malignancies with defective DNA mismatch repair (dMMR): A single institution experience. This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting I.
BOSTON, Mass. (July 15, 2024)—A groundbreaking study conducted at the lab of Beth Stevens, PhD, at Boston Children’s Hospital has revealed that an immune protein impacts neuronal protein synthesis in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results